Evidence map›Paper›PMID 39927253›Full record

ReviewClinical kidney journal2025

Only the Bluesky is the limit: ten tips for a trending #Skytorial.

Jasmine Sethi, Madelena Stauss, Safak Mirioglu, Lauren Floyd, Alexander Woywodt

Abstract readReview
In one paragraph

Review in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jasmine SethiDepartment of Nephrology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Madelena StaussDepartment of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK.
Safak MiriogluDivision of Nephrology, Bezmialem Vakif University Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-0362-8154
Lauren FloydDepartment of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK.
Alexander WoywodtDepartment of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK.ORCID https://orcid.org/0000-0002-3825-6955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Threaded online medical education first emerged on X (formerly Twitter) in early 2018 following the introduction of a threading feature in December 2017, with nephrologists quickly becoming enthusiastic adopters. However, changes like paid features and weakened content moderation have led many nephrologists and allied professionals to migrate to other platforms, which offer the potential for a more suitable environment for learning and discussion. The 2024 US presidential election and growing disillusionment with X has accelerated this shift. By late November 2024, Bluesky appears to have reached critical mass, and we propose that it will become a major social media platform in nephrology. To this end, we provide 10 tips to compose educational material for use on Bluesky. We suggest a clean break with regards to terminology and propose the term 'skytorial'. Starter packs can help rebuild networks on Bluesky. Skytorials need to be planned with thought given to audience and scope. The first post is important: like a hook in fishing, it needs to interest the audience and establish contact. Emojis and visual content can be used to generate interest. Skytorials need to be concise and less is often more. Tagging and the use of hashtags is important, as is a good take-home message. Finally, it is important to check the entire skytorial before posting it. The arena of social media is constantly evolving and the future is difficult to predict. However, given the rapidly growing popularity of Bluesky, we believe nephrologists should now explore the opportunities of the new platform.

Indexed as

communicationeducationsocial mediaTwitterX

Identifiers

PMID39927253
PMCPMC11803304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.